Antibodies for Cancer Therapy Conference 2011
May 9 - 10, 2011
Бостон MA , США
KEYNOTE PRESENTATIONS
Chairperson’s Opening Remarks 8:40 Antibodies for Cancer: Past, Present and Future
Janice Reichert, Ph.D., Research Assistant Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
The majority of development programs for monoclonal antibodies have focused on cancer, resulting in nearly a dozen marketed products and a variety of novel antibody modalities in clinical study. An overview of development and approval trends for novel anti-cancer mAbs, including bispecific antibodies and antibody-drug conjugates, will be discussed.
Kymouse Platform to Generate Highly Selective, Potent and Well-Tolerated Human Antibody-Based Biopharmaceuticals
Sphingosine-1-Phosphate Antibodies as Potential Agents in the Treatment of Cancer and Age-Related Macular Degeneration
Chairperson’s Opening Remarks 8:40 Antibodies for Cancer: Past, Present and Future
Janice Reichert, Ph.D., Research Assistant Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
The majority of development programs for monoclonal antibodies have focused on cancer, resulting in nearly a dozen marketed products and a variety of novel antibody modalities in clinical study. An overview of development and approval trends for novel anti-cancer mAbs, including bispecific antibodies and antibody-drug conjugates, will be discussed.
Kymouse Platform to Generate Highly Selective, Potent and Well-Tolerated Human Antibody-Based Biopharmaceuticals
Sphingosine-1-Phosphate Antibodies as Potential Agents in the Treatment of Cancer and Age-Related Macular Degeneration
Место проведения
Location: Sheraton Boston Hotel & Towers
Обратная связь
Prudential Center, 39 Dalton St. Boston , USA
Похожие мероприятия
Antibodies for Cancer Therapy Conference April 29 - 30, 2013
Antibodies for Cancer Therapy Conference April 30 - May 1, 2012
Antibodies for Cancer Therapy Conference May 9 - 10, 2011
